Ads
related to: b-cell acute lymphoblastic leukemia survival rate- Ordering Guide
View HCP Resources and
Download Ordering Guide
- ALL Treatment Option
Component of Multi-Agent
Chemotherapy for ALL
- About Treatment
Learn About a Potential
ALL Treatment Option.
- Dosing Schedule
Physicians, View Dosing Schedule
and Administration Info.
- Patient Support
Learn More About
Patient Assistance Options.
- Clinical Data
View Safety &
Clinical Data Profile.
- Ordering Guide
Search results
Chronic Lymphocytic Leukemia: Slow-Appearing Symptoms
Verywell Health via Yahoo News· 9 months agoNew therapies are transforming treatment Halfpoint Images / Getty Images Medically reviewed by...
Kite's Tecartus CAR T-Cell Therapy Demonstrates Durable Overall Survival Benefit In Leukemia...
Benzinga via Yahoo Finance· 1 year agoKite, a Gilead Sciences Inc (NASDAQ: GILD) company, announced the three-year follow-up results from...
Gilead (GILD) Kite Reports Positive Data on CAR T-Cell Therapy
Zacks via Yahoo Finance· 1 year agoGilead Sciences’ GILD Kite announced encouraging three-year follow-up results from the ZUMA-3 study...
Community to celebrate Kennedy's bell-ringing celebration
Times Record News via Yahoo News· 8 months agoHenrietta, Clay County and the Wichita Falls area came together during a time of great need to...
Bristol Myers (BMY) Announces CAR T Cell Therapy Breyanzi Data
Zacks via Yahoo Finance· 11 months agoBristol Myers' (BMY) CAR T cell therapy Breyanzi (lisocabtagene maraleucel) shows deep and durable...
Gilead (GILD), Compugen Collaborate for Immunotherapy Program
Zacks via Yahoo Finance· 5 months agoGilead Sciences, Inc. GILD entered into an agreement with clinical-stage cancer immunotherapy...
Gilead (GILD) Gears Up to Report Q4 Earnings: Whats in Store?
Zacks via Yahoo Finance· 3 months agoInvestors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales...
Gilead (GILD) Q4 Earnings Miss Estimates, Sales Top on Veklury
Zacks via Yahoo Finance· 3 months agoGilead (GILD) posts mixed results for the fourth quarter. Sales beat estimates on the...
Autolus Therapeutics plc (NASDAQ:AUTL) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 9 months agoAutolus Therapeutics plc (NASDAQ:AUTL) Q2 2023 Earnings Call Transcript August 6, 2023 Operator:...
Ad
related to: b-cell acute lymphoblastic leukemia survival rate